Thank you.
I'd like to give my next question to Professor Herder.
Professor, a big issue we have in clinical research is that the drug companies, their game is to start a clinical trial and ask the researcher to sign a contract, essentially a gag order, that if they order the trial to be stopped at any given time they must never talk about it again, that it will never see the light of day. That's because many of their trials will show that their drug is not working better than a placebo or that their new drug is actually harming patients and they want to cover that up.
Your recommendations for transparency, would they address the issue of where a trial is registered and stopped? Are you insisting or asking that even the partial evidence from that trial or the partial clinical data be published as well?